WR Wealth Planners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$706 Hold
30
﹤0.01% 960
2024
Q3
$768 Hold
30
﹤0.01% 990
2024
Q2
$704 Hold
30
﹤0.01% 990
2024
Q1
$863 Buy
+30
New +$902 ﹤0.01% 985
2023
Q4
Sell
-30
Closed -$836 224
2023
Q3
$836 Hold
30
﹤0.01% 841
2023
Q2
$1.02K Hold
30
﹤0.01% 826
2023
Q1
$902 Buy
+30
New +$930 ﹤0.01% 838

Other funds holding ARKG

WR Wealth Planners's ARKG Position: Q4 2024 in Review

WR Wealth Planners held its ARK Genomic Revolution ETF (ARKG) position steady in Q4 2024 at 30 shares worth $706. The position accounts for ﹤0.01% of the portfolio, ranked #960.

WR Wealth Planners first reported a position in ARKG in Q1 2023 and has held it in 7 quarters since. The position peaked at $1.02K in Q2 2023. 239 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.

  • WR Wealth Planners held 30 shares of ARK Genomic Revolution ETF worth $706 as of Q4 2024.
  • WR Wealth Planners left its ARK Genomic Revolution ETF share count unchanged in Q4 2024.
  • ARK Genomic Revolution ETF made up ﹤0.01% of WR Wealth Planners's portfolio in Q4 2024, its #960 holding.
  • WR Wealth Planners first reported a position in ARK Genomic Revolution ETF in Q1 2023 and has held it in 7 quarters since.
  • WR Wealth Planners's ARK Genomic Revolution ETF position peaked at $1.02K in Q2 2023.
  • 239 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.

Based on WR Wealth Planners's 13F filing for Q4 2024, filed 5 Feb 2025.